Argentum Targets Emerging Superbug with Antimicrobial Dressing

Argentum Medical’s antimicrobial dressings received an extra bit of validation after strong results from recent lab findings. The Geneva, IL-based company’s Silverlon antimicrobial dressing was found to effectively kill Candida Auris (C. Auris), the emerging “superbug” causing invasive, potentially fatal human infection in more than 30 countries, including the U.S. Argentum Medical commissioned Microbiological Consultants, an independent FDA-registered pharmaceutical testing laboratory, to establish if its metallic wound dressings can destroy C. Auris yeast. C. Auris is resistant to multiple antifungal drugs commonly used to treat Candida infections and is difficult and expensive to identify. In addition, it causes outbreaks in healthcare settings to an extent not seen with other Candida species. And even after industrial cleaning, hospital room surfaces can remain contaminated with this fungus well after a patient has been discharged. “What’s new about [Auris] is that in certain patient populations, especially those that have comorbidities and are elderly is this bug is now causing a lot of issues,” Raul Brizuela, president and CEO of Argentum Medical, told MD+DI. “It’s not something that was commonly found to cause problems in our patient population until recently. As each one of these threats materialize we want t...
Source: MDDI - Category: Medical Devices Authors: Tags: Materials Source Type: news